SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-052214
Filing Date
2020-11-09
Accepted
2020-11-09 08:01:36
Documents
14
Period of Report
2020-11-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sbph-8k_20201106.htm   iXBRL 8-K 45106
2 EX-99.1 sbph-ex991_7.htm EX-99.1 18015
3 GRAPHIC gchhkvef3p02000001.jpg GRAPHIC 14379
  Complete submission text file 0001564590-20-052214.txt   225300

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA sbph-20201106.xsd EX-101.SCH 5788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20201106_lab.xml EX-101.LAB 20227
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20201106_pre.xml EX-101.PRE 12093
7 EXTRACTED XBRL INSTANCE DOCUMENT sbph-8k_20201106_htm.xml XML 3682
Mailing Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748
Business Address 35 PARKWOOD DRIVE SUITE 210 HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 201296171
SIC: 2834 Pharmaceutical Preparations